These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26695141)

  • 21. Sorafenib inhibits the hepatocyte growth factor-mediated epithelial mesenchymal transition in hepatocellular carcinoma.
    Nagai T; Arao T; Furuta K; Sakai K; Kudo K; Kaneda H; Tamura D; Aomatsu K; Kimura H; Fujita Y; Matsumoto K; Saijo N; Kudo M; Nishio K
    Mol Cancer Ther; 2011 Jan; 10(1):169-77. PubMed ID: 21220499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications.
    García-Vilas JA; Medina MÁ
    World J Gastroenterol; 2018 Sep; 24(33):3695-3708. PubMed ID: 30197476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway.
    Ma C; Yang Y; Xu L; Tu W; Chen F; Wang J
    J Cell Physiol; 2020 Mar; 235(3):2506-2520. PubMed ID: 31506952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma.
    Li L; Zheng YL; Jiang C; Fang S; Zeng TT; Zhu YH; Li Y; Xie D; Guan XY
    Cell Death Differ; 2019 Nov; 26(11):2268-2283. PubMed ID: 30778199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma.
    Zhang XL; Huang CX; Zhang J; Inoue A; Zeng SE; Xiao SJ
    Oncol Rep; 2013 Aug; 30(2):809-14. PubMed ID: 23756565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
    Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
    Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
    Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
    World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling.
    Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T
    Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling.
    Lv X; Yu H; Zhang Q; Huang Q; Hong X; Yu T; Lan H; Mei C; Zhang W; Luo H; Pang P; Shan H
    J Cell Mol Med; 2020 Sep; 24(18):10714-10729. PubMed ID: 32746503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y
    Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
    Yang YM; Lee WH; Lee CG; An J; Kim ES; Kim SH; Lee SK; Lee CH; Dhanasekaran DN; Moon A; Hwang S; Lee SJ; Park JW; Kim KM; Kim SG
    Oncogene; 2015 May; 34(22):2910-21. PubMed ID: 25065598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis.
    Han J; Xie C; Pei T; Wang J; Lan Y; Huang K; Cui Y; Wang F; Zhang J; Pan S; Liang Y; Zhen T; Song R; Sun B; Li Y; Shi H; Yang G; Liu X; Zhu M; Wang Y; Li K; Liu Y; Meng F; Liao F; Meng X; Hong X; Liu L
    Cell Death Dis; 2017 Apr; 8(4):e2736. PubMed ID: 28383563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhang P; Dong Z; Cai J; Zhang C; Shen Z; Ke A; Gao D; Fan J; Shi G
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):36-44. PubMed ID: 25816404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.
    Nagahara T; Shiraha H; Sawahara H; Uchida D; Takeuchi Y; Iwamuro M; Kataoka J; Horiguchi S; Kuwaki T; Onishi H; Nakamura S; Takaki A; Nouso K; Yamamoto K
    Oncol Rep; 2015 Sep; 34(3):1169-77. PubMed ID: 26165819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diospyros kaki leaves inhibit HGF/Met signaling-mediated EMT and stemness features in hepatocellular carcinoma.
    Ko H; Huh G; Jung SH; Kwon H; Jeon Y; Park YN; Kim YJ
    Food Chem Toxicol; 2020 Aug; 142():111475. PubMed ID: 32522589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.
    Ogunwobi OO; Puszyk W; Dong HJ; Liu C
    PLoS One; 2013; 8(5):e63765. PubMed ID: 23723997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.